Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Operating Expenses (2016 - 2021)

Phio Pharmaceuticals' Operating Expenses history spans 10 years, with the latest figure at $3.4 million for Q4 2021.

  • For Q4 2021, Operating Expenses rose 40.13% year-over-year to $3.4 million; the TTM value through Dec 2021 reached $13.5 million, up 53.66%, while the annual FY2024 figure was $7.4 million, 31.75% down from the prior year.
  • Operating Expenses reached $3.4 million in Q4 2021 per PHIO's latest filing, down from $3.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $7.1 million in Q1 2017 to a low of $1.5 million in Q3 2018.
  • Average Operating Expenses over 5 years is $2.6 million, with a median of $2.3 million recorded in 2020.
  • Peak YoY movement for Operating Expenses: skyrocketed 214.01% in 2017, then plummeted 68.06% in 2018.
  • A 5-year view of Operating Expenses shows it stood at $2.0 million in 2017, then fell by 13.56% to $1.7 million in 2018, then skyrocketed by 53.92% to $2.7 million in 2019, then dropped by 7.76% to $2.5 million in 2020, then soared by 40.13% to $3.4 million in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Operating Expenses are $3.4 million (Q4 2021), $3.7 million (Q3 2021), and $2.7 million (Q2 2021).